People · Operator
Named in public records as an officer, director or promoter · active 2012–2018 · Biotechnology, Manufacturing, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | — | Biotechnology | Series A | $24.6M | $361.5M | 2012 |
| Envisia Therapeutics, Inc. | — | Biotechnology | Series A | $14.7M | $365.8M | 2015 |
| Triton Consolidated, Inc. | — | Manufacturing | Pre-Seed | $607K | $9.3M | 2016 |
| Forefront Solutions, Inc. | — | Other | Pre-Seed | $415K | $9.6M | 2018 |
Gary Phillips at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Phillips on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Paul Williams | 1 | 18 |
| Stephen Bloch | 1 | 15 |
| Ed Mathers | 1 | 11 |
| Todd Brady | 1 | 7 |
| Adrienne Graves | 1 | 6 |
| Seth Rudnick | 1 | 5 |
| Mehul Patel | 1 | 5 |
| Jesse I. Treu | 1 | 5 |
| Ben Bronstein | 1 | 4 |
| Eric Linsley | 1 | 4 |
| Neal Fowler | 1 | 4 |
| Gerald Cagle | 1 | 4 |
| Todd C. Brady | 1 | 3 |
| William Yelle | 1 | 2 |
| David L. Clark | 1 | 2 |
| Gary J. Phillips | 1 | 2 |
| Martin J. Joyce | 1 | 2 |
| Joshua Reed | 1 | 2 |
| Ben Yerxa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.